178 related articles for article (PubMed ID: 12324923)
1. Pauci-immune extracapillary glomerulonephritis and atheromatous embolization.
Aviles B; Ubeda I; Blanco J; Barrientos A
Am J Kidney Dis; 2002 Oct; 40(4):847-51. PubMed ID: 12324923
[TBL] [Abstract][Full Text] [Related]
2. Histologic and immunohistologic study and clinical presentation of ANCA-associated glomerulonephritis with correlation to ANCA antigen specificity.
Vizjak A; Rott T; Koselj-Kajtna M; Rozman B; Kaplan-Pavlovcic S; Ferluga D
Am J Kidney Dis; 2003 Mar; 41(3):539-49. PubMed ID: 12612976
[TBL] [Abstract][Full Text] [Related]
3. An index for renal outcome in ANCA-associated glomerulonephritis.
Vergunst CE; van Gurp E; Hagen EC; van Houwelingen HC; Hauer HA; Noël LH; Waldherr R; Ferrario F; van der Woude FJ; Bruijn JA; Bajema IM;
Am J Kidney Dis; 2003 Mar; 41(3):532-8. PubMed ID: 12612975
[TBL] [Abstract][Full Text] [Related]
4. Anti-endothelial cell antibodies in antineutrophil cytoplasmic antibodies negative pauci-immune crescentic glomerulonephritis.
Cong M; Chen M; Zhang JJ; Hu Z; Zhao MH
Nephrology (Carlton); 2008 Jun; 13(3):228-34. PubMed ID: 18315705
[TBL] [Abstract][Full Text] [Related]
5. ANCA-associated crescentic glomerulonephritis with mesangial IgA deposits.
Haas M; Jafri J; Bartosh SM; Karp SL; Adler SG; Meehan SM
Am J Kidney Dis; 2000 Oct; 36(4):709-18. PubMed ID: 11007672
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcome of patients with coexistent antineutrophil cytoplasmic antibodies and antibodies against glomerular basement membrane.
Lindic J; Vizjak A; Ferluga D; Kovac D; Ales A; Kveder R; Ponikvar R; Bren A
Ther Apher Dial; 2009 Aug; 13(4):278-81. PubMed ID: 19695059
[TBL] [Abstract][Full Text] [Related]
7. Antineutrophil cytoplasmic antibody negative pauci-immune extracapillary glomerulonephritis.
Villacorta J; Diaz-Crespo F; Acevedo M; Guerrero C; Mollejo M; Fernandez-Juarez G
Nephrology (Carlton); 2016 Apr; 21(4):301-7. PubMed ID: 26369898
[TBL] [Abstract][Full Text] [Related]
8. ANCA glomerulonephritis and vasculitis: a Chapel Hill perspective.
Falk RJ; Nachman PH; Hogan SL; Jennette JC
Semin Nephrol; 2000 May; 20(3):233-43. PubMed ID: 10855933
[TBL] [Abstract][Full Text] [Related]
9. Myeloperoxidase antineutrophil cytoplasmic autoantibody-associated glomerulonephritis in a very elderly patient with generalized vasculitis at autopsy.
Nakamura C; Yorioka N; Nakanishi S; Naito T; Sugimoto N; Kanahara K; Mano M; Katayama S; Ishikawa K
Hiroshima J Med Sci; 1997 Sep; 46(3):99-104. PubMed ID: 9353970
[TBL] [Abstract][Full Text] [Related]
10. Shared idiotypy among patients with myeloperoxidase-anti-neutrophil cytoplasmic autoantibody associated glomerulonephritis and vasculitis.
Nachman PH; Reisner HM; Yang JJ; Jennette JC; Falk RJ
Lab Invest; 1996 Feb; 74(2):519-27. PubMed ID: 8780169
[TBL] [Abstract][Full Text] [Related]
11. [Rapid-detection GBM-ANCA ELISA. An emergency tool for the early diagnosis of type I and II rapidly progressive glomerulonephritis].
Arranz O; Ara J; Rodríguez R; Poveda R; Serra A; Solé-Amigó J; Fort J; Mirapeix E; Darnell A
Nefrologia; 2001; 21(4):349-54. PubMed ID: 11816510
[TBL] [Abstract][Full Text] [Related]
12. Pauci-immune necrotizing glomerulonephritis.
Rutgers A; Sanders JS; Stegeman CA; Kallenberg CG
Rheum Dis Clin North Am; 2010 Aug; 36(3):559-72. PubMed ID: 20688250
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous occurrence of diabetic glomerulosclerosis, IgA nephropathy, crescentic glomerulonephritis, and myeloperoxidase-antineutrophil cytoplasmic antibody seropositivity in a Chinese patient.
Lui SL; Chan KW; Yip PS; Chan TM; Lai KN; Lo WK
Am J Kidney Dis; 2002 Oct; 40(4):E14. PubMed ID: 12324935
[TBL] [Abstract][Full Text] [Related]
14. [Two patients with pulmonary hemorrhage associated with myeloperoxidase-antineutrophil cytoplasmic antibody].
Niho S; Yokota Y; Takemoto T; Fujitaka K; Yamakido M
Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Jan; 35(1):111-6. PubMed ID: 9071167
[TBL] [Abstract][Full Text] [Related]
15. Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis.
Rutgers A; Slot M; van Paassen P; van Breda Vriesman P; Heeringa P; Tervaert JW
Am J Kidney Dis; 2005 Aug; 46(2):253-62. PubMed ID: 16112043
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of prognostic factors for myeloperoxidase anti-neutrophil cytoplasmic antibody- (MPO-ANCA) associated glomerulonephritis.
Okano K; Yumura W; Nitta K; Honda K; Uchida K; Nihei H
Clin Nephrol; 2001 Apr; 55(4):275-81. PubMed ID: 11334312
[TBL] [Abstract][Full Text] [Related]
17. Crescentic glomerulonephritis associated with myeloperoxidase-antineutrophil-cytoplasmic antibodies: first report on the efficacy of primary anti-TNF-alpha treatment.
Zaenker M; Arbach O; Helmchen U; Glorius P; Ludewig S; Braasch E
Int J Tissue React; 2004; 26(3-4):85-92. PubMed ID: 15648440
[TBL] [Abstract][Full Text] [Related]
18. Antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis in scleroderma--a different kind of renal crisis.
Kamen DL; Wigley FM; Brown AN
J Rheumatol; 2006 Sep; 33(9):1886-8. PubMed ID: 16832842
[TBL] [Abstract][Full Text] [Related]
19. Pauci-immune crescentic glomerulonephritis.
Gupta RK
Indian J Pathol Microbiol; 2003 Jul; 46(3):357-66. PubMed ID: 15025274
[TBL] [Abstract][Full Text] [Related]
20. Importance of checking anti-glomerular basement membrane antibody status in patients with anti-neutrophil cytoplasmic antibody-positive vasculitis.
Gallagher JL; Sinha S; Reeve R; Kalra PA
Postgrad Med J; 2008 Apr; 84(990):220-2. PubMed ID: 18424581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]